These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 16430654

  • 21. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
    Nijman RJ, Borgstein NG, Ellsworth P, Djurhuus JC.
    J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M, Glickman S, Haggar V, Barton R, Brooks R, Malone-Lee J.
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [Abstract] [Full Text] [Related]

  • 26. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
    Ohtake A, Saitoh C, Yuyama H, Ukai M, Okutsu H, Noguchi Y, Hatanaka T, Suzuki M, Sato S, Sasamata M, Miyata K.
    Biol Pharm Bull; 2007 Jan; 30(1):54-8. PubMed ID: 17202659
    [Abstract] [Full Text] [Related]

  • 27. The effects of tolterodine on bladder-filling sensations and perception thresholds to intravesical electrical stimulation: method and initial results.
    Boy S, Schurch B, Mehnert U, Mehring G, Karsenty G, Reitz A.
    BJU Int; 2007 Sep; 100(3):574-8. PubMed ID: 17669142
    [Abstract] [Full Text] [Related]

  • 28. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M, Nomura M, Nishii H, Matsumoto S, Fujimoto N, Matsumoto T.
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [Abstract] [Full Text] [Related]

  • 29. Tolterodine--a new bladder-selective antimuscarinic agent.
    Nilvebrant L, Andersson KE, Gillberg PG, Stahl M, Sparf B.
    Eur J Pharmacol; 1997 May 30; 327(2-3):195-207. PubMed ID: 9200560
    [Abstract] [Full Text] [Related]

  • 30. Tolterodine: selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteers.
    Chapple CR, Nilvebrant L.
    Drugs R D; 2002 May 30; 3(2):75-81. PubMed ID: 12001821
    [Abstract] [Full Text] [Related]

  • 31. Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity.
    Reddy PP, Borgstein NG, Nijman RJ, Ellsworth PI.
    J Pediatr Urol; 2008 Dec 30; 4(6):428-33. PubMed ID: 19013412
    [Abstract] [Full Text] [Related]

  • 32. Propiverine versus tolterodine: efficacy and tolerability in patients with overactive bladder.
    Jünemann KP, Halaska M, Rittstein T, Mürtz G, Schnabel F, Brünjes R, Nurkiewicz W.
    Eur Urol; 2005 Sep 30; 48(3):478-82. PubMed ID: 15967567
    [Abstract] [Full Text] [Related]

  • 33. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
    Abrams P, Kaplan S, De Koning Gans HJ, Millard R.
    J Urol; 2006 Mar 30; 175(3 Pt 1):999-1004; discussion 1004. PubMed ID: 16469601
    [Abstract] [Full Text] [Related]

  • 34. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
    Atiemo H, Wynes J, Chuo J, Nipkow L, Sklar GN, Chai TC.
    Urology; 2005 Mar 30; 65(3):622-6. PubMed ID: 15780404
    [Abstract] [Full Text] [Related]

  • 35. Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle.
    Yono M, Yoshida M, Takahashi W, Inadome A, Ueda S.
    BJU Int; 2000 Oct 30; 86(6):719-25. PubMed ID: 11069384
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
    Hatanaka T, Ukai M, Watanabe M, Someya A, Ohtake A, Suzuki M, Ueshima K, Sato S, Kaku S.
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan 30; 386(1):71-8. PubMed ID: 23224420
    [Abstract] [Full Text] [Related]

  • 38. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
    De Wachter S, Wyndaele JJ.
    J Urol; 2003 May 30; 169(5):1892-5. PubMed ID: 12686868
    [Abstract] [Full Text] [Related]

  • 39. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
    Yokoyama O, Ishiura Y, Nakamura Y, Ohkawa M.
    J Urol; 1996 Feb 30; 155(2):768-71. PubMed ID: 8558722
    [Abstract] [Full Text] [Related]

  • 40. Detrusor overactivity induced by intravesical application of adenosine 5'-triphosphate under different delivery conditions in rats.
    Nishiguchi J, Hayashi Y, Chancellor MB, de Miguel F, de Groat WC, Kumon H, Yoshimura N.
    Urology; 2005 Dec 30; 66(6):1332-7. PubMed ID: 16360479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.